U.S. STOCKS ON THE MOVE-Ross Stores, Alibaba, ChargePoint
Brief: Bone Biologics Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR
Brief: Bone Biologics Corp Received Notice From Nasdaq Notifying Co Failed To Comply With $1.00 Per Share Minimum Bid Price Requirement
Brief: Bone Biologics Provides Scientific Update On Nb1 Bone Graft Device
Brief: Bone Biologics Got Letter From Nasdaq Confirming Decision Of Panel That Co Currently Shows Compliance With Continued Listing Requirements
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: Bone Biologics Prices $5 Mln Underwritten Public Offering
U.S. STOCKS ON THE MOVE-Rio Tinto, BurgerFi International, Aclaris Therapeutics
Bone Biologics announces secondary stock offering; shares down
Brief: Bone Biologics Effects 1-For-30 Reverse Stock Split
Brief: Bone Biologics - On May 18, Co Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard Transfer Of Listing From Nasdaq
Brief: Bone Biologics Receives Human Research Ethics Committee Approval To Begin Pilot Clinical Trial With Nb1 In Spinal Fusion Patients In Australia
Brief: Bone Biologics Advances Preparations For Nb1 Pilot Clinical Trial With Engagement Of Contract Research Organization
Brief: Bone Biologics Corp Gets Notice Of Delisting Or Failure To Satisfy A Continue Listing Rule Or Standard From Nasdaq
Brief: Wallachbeth Capital Announces Closing Of Bone Biologics $5,100,000 Underwritten Public Offering
Brief: Bone Biologics Prices $5,100,000 Million Underwritten Public Offering
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:30 PM
Brief: Bone Biologics Enters Into Supply Agreement With MTF Biologics For Demineralized Bone Matrix